» Authors » Eva Vigo

Eva Vigo

Explore the profile of Eva Vigo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 281
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Carrera A, Vigo E, Regueiro-Rodriguez C, Gonzalez-Fernandez A, Olivieri D, Aroeira L
Lab Invest . 2017 Jul; 97(9):1114-1120. PMID: 28737767
Tissue membranes are boundaries that isolate organs or cavities in the body. These semi-permeable membranes are responsible for passive protection that acts through the regulation of nutrient absorption, secretion and...
2.
Lopez-Alvarez M, Vigo E, Rodriguez-Valencia C, Outeirino-Iglesias V, Gonzalez P, Serra J
Clin Oral Implants Res . 2016 Aug; 28(9):e91-e100. PMID: 27492736
Objective: The present work proposes the shark teeth as a new source of bioapatites for bone filler applications in maxillary sinus elevation, periodontal regeneration or implants placement. This abundant fishing...
3.
Outeirino-Iglesias V, Romani-Perez M, Gonzalez-Matias L, Vigo E, Mallo F
Endocrinology . 2015 Aug; 156(11):4226-37. PMID: 26252058
Control of estrous cycle and reproductive capacity involves a large number of central and peripheral factors, integrating numerous nutritional and metabolic signals. Here we show that glucagon-like peptide-1 (GLP-1), a...
4.
Romani-Perez M, Outeirino-Iglesias V, Moya C, Santisteban P, Gonzalez-Matias L, Vigo E, et al.
Endocrinology . 2015 Jul; 156(10):3559-69. PMID: 26196539
Diabetes alters microvascular function in the vascular beds of organs, including the lungs. Cardiovascular complications of pulmonary vascular affectation may be a consequence of the overactivation of the vasoconstrictive and...
5.
Gil-Lozano M, Romani-Perez M, Outeirino-Iglesias V, Vigo E, Gonzalez-Matias L, Brubaker P, et al.
Endocrinology . 2014 Apr; 155(7):2511-23. PMID: 24731096
Glucagon-like peptide-1 (GLP-1) and the GLP-1 receptor agonist, exendin-4 (Ex-4), potently stimulate hypothalamic-pituitary-adrenal (HPA) axis activity after either central or peripheral administration. Because several GLP-1 derivative drugs, including synthetic Ex-4,...
6.
Gil-Lozano M, Romani-Perez M, Outeirino-Iglesias V, Vigo E, Brubaker P, Gonzalez-Matias L, et al.
Am J Physiol Endocrinol Metab . 2013 Mar; 304(10):E1105-17. PMID: 23531615
Exendin-4 (Ex-4) is a natural agonist of the glucagon-like peptide-1 (GLP-1) receptor, currently being used as a treatment for type 2 diabetes mellitus due to its insulinotropic properties. Previous studies...
7.
Romani-Perez M, Outeirino-Iglesias V, Gil-Lozano M, Gonzalez-Matias L, Mallo F, Vigo E
Endocrinology . 2013 Jan; 154(3):1144-55. PMID: 23354098
The glucagon-like peptide-1 receptor (GLP-1R) is found in a variety of tissues outside of the pancreas. For example, GLP-1R is expressed in the lung, where it has been implicated in...
8.
Vigo E, Roa J, Pineda R, Castellano J, Navarro V, Aguilar E, et al.
Am J Physiol Endocrinol Metab . 2007 Aug; 293(5):E1265-73. PMID: 17726140
Neuromedin U (NMU) is a widely spread neuropeptide, with predominant expression at the gastrointestinal tract and brain, putatively involved in the regulation of a diversity of biological functions, including food...
9.
Castellano J, Navarro V, Fernandez-Fernandez R, Roa J, Vigo E, Pineda R, et al.
Diabetes . 2006 Aug; 55(9):2602-10. PMID: 16936210
Hypogonadotropism is a common feature of uncontrolled diabetes, for which the ultimate mechanism remains to be elucidated. Kisspeptins, ligands of G protein-coupled receptor 54 (GPR54) encoded by the KiSS-1 gene,...
10.
Fraga C, Blanco M, Vigo E, Segura C, Garcia-Caballero T, Perez-Fernandez R
Histochem Cell Biol . 2002 Jul; 117(6):547-50. PMID: 12107506
1,25-Dihydroxyvitamin D(3) through its receptor (vitamin D receptor; VDR) has important physiological effects such as calcium transport and cell growth and differentiation. Although the VDR is present in a variety...